I don't know if I am looking at this properly but the 33 million shares MWC bought had 60 cent warrants due in March 2, 2014, roughly $20 million.  SDI should have about $9 million which is about what it will cost for another year of trials.  Outside of the FDA giving a thumbs down one would think the warrants would be in the money especially if the next round of trials prove successful.

My point is I don't see a lot of dilution happening and anything under 20 cents is going to look good next year.  Or am I just missing something?